Global Microneedle Flu Vaccine Market Insights, Forecast to 2029
This report presents an overview of global market for Microneedle Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Microneedle Flu Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Microneedle Flu Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microneedle Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Microneedle Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Microneedle Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals and Microdermics and OraSure Technologies, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Microneedle Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microneedle Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Microneedle Flu Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Microneedle Flu Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microneedle Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Microneedle Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Microneedle Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals and Microdermics and OraSure Technologies, etc.
By Company
- Sanofi
- GC Pharma
- Debiotech
- NanoPass Technologies
- Corium International
- Becton Dickinson and Company
- FluGen
- CosMED Pharmaceuticals
- Microdermics and OraSure Technologies
- Solid Microneedle
- Hollow Microneedle
- Coated Microneedle
- Dissolving Microneedle
- Influenza A
- Influenza B
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Microneedle Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microneedle Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Microneedle Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Market by Application
1.3.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Microneedle Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Microneedle Flu Vaccine Revenue by Region
2.2.1 Global Microneedle Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Microneedle Flu Vaccine Revenue by Region (2018-2023)
2.2.3 Global Microneedle Flu Vaccine Revenue by Region (2024-2029)
2.2.4 Global Microneedle Flu Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Microneedle Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Microneedle Flu Vaccine Sales by Region
2.4.1 Global Microneedle Flu Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Microneedle Flu Vaccine Sales by Region (2018-2023)
2.4.3 Global Microneedle Flu Vaccine Sales by Region (2024-2029)
2.4.4 Global Microneedle Flu Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Microneedle Flu Vaccine Sales by Manufacturers
3.1.1 Global Microneedle Flu Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microneedle Flu Vaccine in 2022
3.2 Global Microneedle Flu Vaccine Revenue by Manufacturers
3.2.1 Global Microneedle Flu Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Microneedle Flu Vaccine Revenue in 2022
3.3 Global Key Players of Microneedle Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Microneedle Flu Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Microneedle Flu Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Microneedle Flu Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Microneedle Flu Vaccine Sales by Type
4.1.1 Global Microneedle Flu Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Microneedle Flu Vaccine Revenue by Type
4.2.1 Global Microneedle Flu Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Microneedle Flu Vaccine Price by Type
4.3.1 Global Microneedle Flu Vaccine Price by Type (2018-2023)
4.3.2 Global Microneedle Flu Vaccine Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Microneedle Flu Vaccine Sales by Application
5.1.1 Global Microneedle Flu Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Microneedle Flu Vaccine Revenue by Application
5.2.1 Global Microneedle Flu Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Microneedle Flu Vaccine Price by Application
5.3.1 Global Microneedle Flu Vaccine Price by Application (2018-2023)
5.3.2 Global Microneedle Flu Vaccine Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Microneedle Flu Vaccine Market Size by Type
6.1.1 US & Canada Microneedle Flu Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Microneedle Flu Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Microneedle Flu Vaccine Market Size by Application
6.2.1 US & Canada Microneedle Flu Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Microneedle Flu Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Microneedle Flu Vaccine Market Size by Country
6.3.1 US & Canada Microneedle Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Microneedle Flu Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Microneedle Flu Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Microneedle Flu Vaccine Market Size by Type
7.1.1 Europe Microneedle Flu Vaccine Sales by Type (2018-2029)
7.1.2 Europe Microneedle Flu Vaccine Revenue by Type (2018-2029)
7.2 Europe Microneedle Flu Vaccine Market Size by Application
7.2.1 Europe Microneedle Flu Vaccine Sales by Application (2018-2029)
7.2.2 Europe Microneedle Flu Vaccine Revenue by Application (2018-2029)
7.3 Europe Microneedle Flu Vaccine Market Size by Country
7.3.1 Europe Microneedle Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Microneedle Flu Vaccine Sales by Country (2018-2029)
7.3.3 Europe Microneedle Flu Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Microneedle Flu Vaccine Market Size
8.1.1 China Microneedle Flu Vaccine Sales (2018-2029)
8.1.2 China Microneedle Flu Vaccine Revenue (2018-2029)
8.2 China Microneedle Flu Vaccine Market Size by Application
8.2.1 China Microneedle Flu Vaccine Sales by Application (2018-2029)
8.2.2 China Microneedle Flu Vaccine Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Microneedle Flu Vaccine Market Size by Type
9.1.1 Asia Microneedle Flu Vaccine Sales by Type (2018-2029)
9.1.2 Asia Microneedle Flu Vaccine Revenue by Type (2018-2029)
9.2 Asia Microneedle Flu Vaccine Market Size by Application
9.2.1 Asia Microneedle Flu Vaccine Sales by Application (2018-2029)
9.2.2 Asia Microneedle Flu Vaccine Revenue by Application (2018-2029)
9.3 Asia Microneedle Flu Vaccine Sales by Region
9.3.1 Asia Microneedle Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Microneedle Flu Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Microneedle Flu Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GC Pharma
11.2.1 GC Pharma Company Information
11.2.2 GC Pharma Overview
11.2.3 GC Pharma Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GC Pharma Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GC Pharma Recent Developments
11.3 Debiotech
11.3.1 Debiotech Company Information
11.3.2 Debiotech Overview
11.3.3 Debiotech Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Debiotech Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Debiotech Recent Developments
11.4 NanoPass Technologies
11.4.1 NanoPass Technologies Company Information
11.4.2 NanoPass Technologies Overview
11.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 NanoPass Technologies Recent Developments
11.5 Corium International
11.5.1 Corium International Company Information
11.5.2 Corium International Overview
11.5.3 Corium International Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Corium International Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Corium International Recent Developments
11.6 Becton Dickinson and Company
11.6.1 Becton Dickinson and Company Company Information
11.6.2 Becton Dickinson and Company Overview
11.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Becton Dickinson and Company Recent Developments
11.7 FluGen
11.7.1 FluGen Company Information
11.7.2 FluGen Overview
11.7.3 FluGen Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 FluGen Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 FluGen Recent Developments
11.8 CosMED Pharmaceuticals
11.8.1 CosMED Pharmaceuticals Company Information
11.8.2 CosMED Pharmaceuticals Overview
11.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CosMED Pharmaceuticals Recent Developments
11.9 Microdermics and OraSure Technologies
11.9.1 Microdermics and OraSure Technologies Company Information
11.9.2 Microdermics and OraSure Technologies Overview
11.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Microdermics and OraSure Technologies Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Microneedle Flu Vaccine Industry Chain Analysis
12.2 Microneedle Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microneedle Flu Vaccine Production Mode & Process
12.4 Microneedle Flu Vaccine Sales and Marketing
12.4.1 Microneedle Flu Vaccine Sales Channels
12.4.2 Microneedle Flu Vaccine Distributors
12.5 Microneedle Flu Vaccine Customers
13 MARKET DYNAMICS
13.1 Microneedle Flu Vaccine Industry Trends
13.2 Microneedle Flu Vaccine Market Drivers
13.3 Microneedle Flu Vaccine Market Challenges
13.4 Microneedle Flu Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL MICRONEEDLE FLU VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Microneedle Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Market by Application
1.3.1 Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Microneedle Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Microneedle Flu Vaccine Revenue by Region
2.2.1 Global Microneedle Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Microneedle Flu Vaccine Revenue by Region (2018-2023)
2.2.3 Global Microneedle Flu Vaccine Revenue by Region (2024-2029)
2.2.4 Global Microneedle Flu Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Microneedle Flu Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Microneedle Flu Vaccine Sales by Region
2.4.1 Global Microneedle Flu Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Microneedle Flu Vaccine Sales by Region (2018-2023)
2.4.3 Global Microneedle Flu Vaccine Sales by Region (2024-2029)
2.4.4 Global Microneedle Flu Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Microneedle Flu Vaccine Sales by Manufacturers
3.1.1 Global Microneedle Flu Vaccine Sales by Manufacturers (2018-2023)
3.1.2 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microneedle Flu Vaccine in 2022
3.2 Global Microneedle Flu Vaccine Revenue by Manufacturers
3.2.1 Global Microneedle Flu Vaccine Revenue by Manufacturers (2018-2023)
3.2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Microneedle Flu Vaccine Revenue in 2022
3.3 Global Key Players of Microneedle Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Microneedle Flu Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Microneedle Flu Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Microneedle Flu Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Microneedle Flu Vaccine Sales by Type
4.1.1 Global Microneedle Flu Vaccine Historical Sales by Type (2018-2023)
4.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Microneedle Flu Vaccine Revenue by Type
4.2.1 Global Microneedle Flu Vaccine Historical Revenue by Type (2018-2023)
4.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Microneedle Flu Vaccine Price by Type
4.3.1 Global Microneedle Flu Vaccine Price by Type (2018-2023)
4.3.2 Global Microneedle Flu Vaccine Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Microneedle Flu Vaccine Sales by Application
5.1.1 Global Microneedle Flu Vaccine Historical Sales by Application (2018-2023)
5.1.2 Global Microneedle Flu Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Microneedle Flu Vaccine Revenue by Application
5.2.1 Global Microneedle Flu Vaccine Historical Revenue by Application (2018-2023)
5.2.2 Global Microneedle Flu Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Microneedle Flu Vaccine Price by Application
5.3.1 Global Microneedle Flu Vaccine Price by Application (2018-2023)
5.3.2 Global Microneedle Flu Vaccine Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Microneedle Flu Vaccine Market Size by Type
6.1.1 US & Canada Microneedle Flu Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Microneedle Flu Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Microneedle Flu Vaccine Market Size by Application
6.2.1 US & Canada Microneedle Flu Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Microneedle Flu Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Microneedle Flu Vaccine Market Size by Country
6.3.1 US & Canada Microneedle Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Microneedle Flu Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Microneedle Flu Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Microneedle Flu Vaccine Market Size by Type
7.1.1 Europe Microneedle Flu Vaccine Sales by Type (2018-2029)
7.1.2 Europe Microneedle Flu Vaccine Revenue by Type (2018-2029)
7.2 Europe Microneedle Flu Vaccine Market Size by Application
7.2.1 Europe Microneedle Flu Vaccine Sales by Application (2018-2029)
7.2.2 Europe Microneedle Flu Vaccine Revenue by Application (2018-2029)
7.3 Europe Microneedle Flu Vaccine Market Size by Country
7.3.1 Europe Microneedle Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Microneedle Flu Vaccine Sales by Country (2018-2029)
7.3.3 Europe Microneedle Flu Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Microneedle Flu Vaccine Market Size
8.1.1 China Microneedle Flu Vaccine Sales (2018-2029)
8.1.2 China Microneedle Flu Vaccine Revenue (2018-2029)
8.2 China Microneedle Flu Vaccine Market Size by Application
8.2.1 China Microneedle Flu Vaccine Sales by Application (2018-2029)
8.2.2 China Microneedle Flu Vaccine Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Microneedle Flu Vaccine Market Size by Type
9.1.1 Asia Microneedle Flu Vaccine Sales by Type (2018-2029)
9.1.2 Asia Microneedle Flu Vaccine Revenue by Type (2018-2029)
9.2 Asia Microneedle Flu Vaccine Market Size by Application
9.2.1 Asia Microneedle Flu Vaccine Sales by Application (2018-2029)
9.2.2 Asia Microneedle Flu Vaccine Revenue by Application (2018-2029)
9.3 Asia Microneedle Flu Vaccine Sales by Region
9.3.1 Asia Microneedle Flu Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Microneedle Flu Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Microneedle Flu Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GC Pharma
11.2.1 GC Pharma Company Information
11.2.2 GC Pharma Overview
11.2.3 GC Pharma Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 GC Pharma Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GC Pharma Recent Developments
11.3 Debiotech
11.3.1 Debiotech Company Information
11.3.2 Debiotech Overview
11.3.3 Debiotech Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Debiotech Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Debiotech Recent Developments
11.4 NanoPass Technologies
11.4.1 NanoPass Technologies Company Information
11.4.2 NanoPass Technologies Overview
11.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 NanoPass Technologies Recent Developments
11.5 Corium International
11.5.1 Corium International Company Information
11.5.2 Corium International Overview
11.5.3 Corium International Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Corium International Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Corium International Recent Developments
11.6 Becton Dickinson and Company
11.6.1 Becton Dickinson and Company Company Information
11.6.2 Becton Dickinson and Company Overview
11.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Becton Dickinson and Company Recent Developments
11.7 FluGen
11.7.1 FluGen Company Information
11.7.2 FluGen Overview
11.7.3 FluGen Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 FluGen Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 FluGen Recent Developments
11.8 CosMED Pharmaceuticals
11.8.1 CosMED Pharmaceuticals Company Information
11.8.2 CosMED Pharmaceuticals Overview
11.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CosMED Pharmaceuticals Recent Developments
11.9 Microdermics and OraSure Technologies
11.9.1 Microdermics and OraSure Technologies Company Information
11.9.2 Microdermics and OraSure Technologies Overview
11.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Microdermics and OraSure Technologies Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Microneedle Flu Vaccine Industry Chain Analysis
12.2 Microneedle Flu Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microneedle Flu Vaccine Production Mode & Process
12.4 Microneedle Flu Vaccine Sales and Marketing
12.4.1 Microneedle Flu Vaccine Sales Channels
12.4.2 Microneedle Flu Vaccine Distributors
12.5 Microneedle Flu Vaccine Customers
13 MARKET DYNAMICS
13.1 Microneedle Flu Vaccine Industry Trends
13.2 Microneedle Flu Vaccine Market Drivers
13.3 Microneedle Flu Vaccine Market Challenges
13.4 Microneedle Flu Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL MICRONEEDLE FLU VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Solid Microneedle
Table 3. Major Manufacturers of Hollow Microneedle
Table 4. Major Manufacturers of Coated Microneedle
Table 5. Major Manufacturers of Dissolving Microneedle
Table 6. Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Microneedle Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Microneedle Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Microneedle Flu Vaccine Revenue Market Share by Region (2018-2023)
Table 11. Global Microneedle Flu Vaccine Revenue Market Share by Region (2024-2029)
Table 12. Global Microneedle Flu Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Microneedle Flu Vaccine Sales by Region (2018-2023) & (K Dose)
Table 14. Global Microneedle Flu Vaccine Sales by Region (2024-2029) & (K Dose)
Table 15. Global Microneedle Flu Vaccine Sales Market Share by Region (2018-2023)
Table 16. Global Microneedle Flu Vaccine Sales Market Share by Region (2024-2029)
Table 17. Global Microneedle Flu Vaccine Sales by Manufacturers (2018-2023) & (K Dose)
Table 18. Global Microneedle Flu Vaccine Sales Share by Manufacturers (2018-2023)
Table 19. Global Microneedle Flu Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Microneedle Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Microneedle Flu Vaccine Price by Manufacturers 2018-2023 (US$/Dose)
Table 23. Global Microneedle Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2022)
Table 25. Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Microneedle Flu Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Microneedle Flu Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 30. Global Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 31. Global Microneedle Flu Vaccine Sales Share by Type (2018-2023)
Table 32. Global Microneedle Flu Vaccine Sales Share by Type (2024-2029)
Table 33. Global Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Microneedle Flu Vaccine Revenue Share by Type (2018-2023)
Table 36. Global Microneedle Flu Vaccine Revenue Share by Type (2024-2029)
Table 37. Microneedle Flu Vaccine Price by Type (2018-2023) & (US$/Dose)
Table 38. Global Microneedle Flu Vaccine Price Forecast by Type (2024-2029) & (US$/Dose)
Table 39. Global Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 40. Global Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 41. Global Microneedle Flu Vaccine Sales Share by Application (2018-2023)
Table 42. Global Microneedle Flu Vaccine Sales Share by Application (2024-2029)
Table 43. Global Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Microneedle Flu Vaccine Revenue Share by Application (2018-2023)
Table 46. Global Microneedle Flu Vaccine Revenue Share by Application (2024-2029)
Table 47. Microneedle Flu Vaccine Price by Application (2018-2023) & (US$/Dose)
Table 48. Global Microneedle Flu Vaccine Price Forecast by Application (2024-2029) & (US$/Dose)
Table 49. US & Canada Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 50. US & Canada Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 51. US & Canada Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 54. US & Canada Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 55. US & Canada Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Microneedle Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Microneedle Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Microneedle Flu Vaccine Sales by Country (2018-2023) & (K Dose)
Table 61. US & Canada Microneedle Flu Vaccine Sales by Country (2024-2029) & (K Dose)
Table 62. Europe Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 63. Europe Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 64. Europe Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 67. Europe Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 68. Europe Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Microneedle Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Microneedle Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Microneedle Flu Vaccine Sales by Country (2018-2023) & (K Dose)
Table 74. Europe Microneedle Flu Vaccine Sales by Country (2024-2029) & (K Dose)
Table 75. China Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 76. China Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 77. China Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 80. China Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 81. China Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 84. Asia Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 85. Asia Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 88. Asia Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 89. Asia Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Microneedle Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Microneedle Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Microneedle Flu Vaccine Sales by Region (2018-2023) & (K Dose)
Table 95. Asia Microneedle Flu Vaccine Sales by Region (2024-2029) & (K Dose)
Table 96. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 97. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 98. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 101. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 102. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country (2018-2023) & (K Dose)
Table 108. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country (2024-2029) & (K Dose)
Table 109. Sanofi Company Information
Table 110. Sanofi Description and Major Businesses
Table 111. Sanofi Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 112. Sanofi Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Sanofi Recent Developments
Table 114. GC Pharma Company Information
Table 115. GC Pharma Description and Major Businesses
Table 116. GC Pharma Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 117. GC Pharma Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. GC Pharma Recent Developments
Table 119. Debiotech Company Information
Table 120. Debiotech Description and Major Businesses
Table 121. Debiotech Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 122. Debiotech Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Debiotech Recent Developments
Table 124. NanoPass Technologies Company Information
Table 125. NanoPass Technologies Description and Major Businesses
Table 126. NanoPass Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 127. NanoPass Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. NanoPass Technologies Recent Developments
Table 129. Corium International Company Information
Table 130. Corium International Description and Major Businesses
Table 131. Corium International Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 132. Corium International Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Corium International Recent Developments
Table 134. Becton Dickinson and Company Company Information
Table 135. Becton Dickinson and Company Description and Major Businesses
Table 136. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 137. Becton Dickinson and Company Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Becton Dickinson and Company Recent Developments
Table 139. FluGen Company Information
Table 140. FluGen Description and Major Businesses
Table 141. FluGen Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 142. FluGen Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. FluGen Recent Developments
Table 144. CosMED Pharmaceuticals Company Information
Table 145. CosMED Pharmaceuticals Description and Major Businesses
Table 146. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 147. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. CosMED Pharmaceuticals Recent Developments
Table 149. Microdermics and OraSure Technologies Company Information
Table 150. Microdermics and OraSure Technologies Description and Major Businesses
Table 151. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 152. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Microdermics and OraSure Technologies Recent Developments
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Microneedle Flu Vaccine Distributors List
Table 157. Microneedle Flu Vaccine Customers List
Table 158. Microneedle Flu Vaccine Market Trends
Table 159. Microneedle Flu Vaccine Market Drivers
Table 160. Microneedle Flu Vaccine Market Challenges
Table 161. Microneedle Flu Vaccine Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
Table 1. Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Solid Microneedle
Table 3. Major Manufacturers of Hollow Microneedle
Table 4. Major Manufacturers of Coated Microneedle
Table 5. Major Manufacturers of Dissolving Microneedle
Table 6. Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Microneedle Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Microneedle Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Microneedle Flu Vaccine Revenue Market Share by Region (2018-2023)
Table 11. Global Microneedle Flu Vaccine Revenue Market Share by Region (2024-2029)
Table 12. Global Microneedle Flu Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Microneedle Flu Vaccine Sales by Region (2018-2023) & (K Dose)
Table 14. Global Microneedle Flu Vaccine Sales by Region (2024-2029) & (K Dose)
Table 15. Global Microneedle Flu Vaccine Sales Market Share by Region (2018-2023)
Table 16. Global Microneedle Flu Vaccine Sales Market Share by Region (2024-2029)
Table 17. Global Microneedle Flu Vaccine Sales by Manufacturers (2018-2023) & (K Dose)
Table 18. Global Microneedle Flu Vaccine Sales Share by Manufacturers (2018-2023)
Table 19. Global Microneedle Flu Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Microneedle Flu Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Microneedle Flu Vaccine Price by Manufacturers 2018-2023 (US$/Dose)
Table 23. Global Microneedle Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2022)
Table 25. Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Microneedle Flu Vaccine, Product Offered and Application
Table 27. Global Key Manufacturers of Microneedle Flu Vaccine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 30. Global Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 31. Global Microneedle Flu Vaccine Sales Share by Type (2018-2023)
Table 32. Global Microneedle Flu Vaccine Sales Share by Type (2024-2029)
Table 33. Global Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Microneedle Flu Vaccine Revenue Share by Type (2018-2023)
Table 36. Global Microneedle Flu Vaccine Revenue Share by Type (2024-2029)
Table 37. Microneedle Flu Vaccine Price by Type (2018-2023) & (US$/Dose)
Table 38. Global Microneedle Flu Vaccine Price Forecast by Type (2024-2029) & (US$/Dose)
Table 39. Global Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 40. Global Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 41. Global Microneedle Flu Vaccine Sales Share by Application (2018-2023)
Table 42. Global Microneedle Flu Vaccine Sales Share by Application (2024-2029)
Table 43. Global Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Microneedle Flu Vaccine Revenue Share by Application (2018-2023)
Table 46. Global Microneedle Flu Vaccine Revenue Share by Application (2024-2029)
Table 47. Microneedle Flu Vaccine Price by Application (2018-2023) & (US$/Dose)
Table 48. Global Microneedle Flu Vaccine Price Forecast by Application (2024-2029) & (US$/Dose)
Table 49. US & Canada Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 50. US & Canada Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 51. US & Canada Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 54. US & Canada Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 55. US & Canada Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Microneedle Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Microneedle Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Microneedle Flu Vaccine Sales by Country (2018-2023) & (K Dose)
Table 61. US & Canada Microneedle Flu Vaccine Sales by Country (2024-2029) & (K Dose)
Table 62. Europe Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 63. Europe Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 64. Europe Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 67. Europe Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 68. Europe Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Microneedle Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Microneedle Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Microneedle Flu Vaccine Sales by Country (2018-2023) & (K Dose)
Table 74. Europe Microneedle Flu Vaccine Sales by Country (2024-2029) & (K Dose)
Table 75. China Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 76. China Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 77. China Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 80. China Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 81. China Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 84. Asia Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 85. Asia Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 88. Asia Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 89. Asia Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Microneedle Flu Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Microneedle Flu Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Microneedle Flu Vaccine Sales by Region (2018-2023) & (K Dose)
Table 95. Asia Microneedle Flu Vaccine Sales by Region (2024-2029) & (K Dose)
Table 96. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Type (2018-2023) & (K Dose)
Table 97. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Type (2024-2029) & (K Dose)
Table 98. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Application (2018-2023) & (K Dose)
Table 101. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Application (2024-2029) & (K Dose)
Table 102. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country (2018-2023) & (K Dose)
Table 108. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales by Country (2024-2029) & (K Dose)
Table 109. Sanofi Company Information
Table 110. Sanofi Description and Major Businesses
Table 111. Sanofi Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 112. Sanofi Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Sanofi Recent Developments
Table 114. GC Pharma Company Information
Table 115. GC Pharma Description and Major Businesses
Table 116. GC Pharma Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 117. GC Pharma Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. GC Pharma Recent Developments
Table 119. Debiotech Company Information
Table 120. Debiotech Description and Major Businesses
Table 121. Debiotech Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 122. Debiotech Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Debiotech Recent Developments
Table 124. NanoPass Technologies Company Information
Table 125. NanoPass Technologies Description and Major Businesses
Table 126. NanoPass Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 127. NanoPass Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. NanoPass Technologies Recent Developments
Table 129. Corium International Company Information
Table 130. Corium International Description and Major Businesses
Table 131. Corium International Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 132. Corium International Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Corium International Recent Developments
Table 134. Becton Dickinson and Company Company Information
Table 135. Becton Dickinson and Company Description and Major Businesses
Table 136. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 137. Becton Dickinson and Company Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Becton Dickinson and Company Recent Developments
Table 139. FluGen Company Information
Table 140. FluGen Description and Major Businesses
Table 141. FluGen Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 142. FluGen Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. FluGen Recent Developments
Table 144. CosMED Pharmaceuticals Company Information
Table 145. CosMED Pharmaceuticals Description and Major Businesses
Table 146. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 147. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. CosMED Pharmaceuticals Recent Developments
Table 149. Microdermics and OraSure Technologies Company Information
Table 150. Microdermics and OraSure Technologies Description and Major Businesses
Table 151. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 152. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Microdermics and OraSure Technologies Recent Developments
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Microneedle Flu Vaccine Distributors List
Table 157. Microneedle Flu Vaccine Customers List
Table 158. Microneedle Flu Vaccine Market Trends
Table 159. Microneedle Flu Vaccine Market Drivers
Table 160. Microneedle Flu Vaccine Market Challenges
Table 161. Microneedle Flu Vaccine Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Microneedle Flu Vaccine Product Picture
Figure 2. Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Microneedle Flu Vaccine Market Share by Type in 2022 & 2029
Figure 4. Solid Microneedle Product Picture
Figure 5. Hollow Microneedle Product Picture
Figure 6. Coated Microneedle Product Picture
Figure 7. Dissolving Microneedle Product Picture
Figure 8. Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Microneedle Flu Vaccine Market Share by Application in 2022 & 2029
Figure 10. Influenza A
Figure 11. Influenza B
Figure 12. Microneedle Flu Vaccine Report Years Considered
Figure 13. Global Microneedle Flu Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Microneedle Flu Vaccine Revenue 2018-2029 (US$ Million)
Figure 15. Global Microneedle Flu Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Microneedle Flu Vaccine Revenue Market Share by Region (2018-2029)
Figure 17. Global Microneedle Flu Vaccine Sales 2018-2029 ((K Dose)
Figure 18. Global Microneedle Flu Vaccine Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 20. US & Canada Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 22. Europe Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 24. China Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 26. Asia (excluding China) Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 28. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Microneedle Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Microneedle Flu Vaccine in the World: Market Share by Microneedle Flu Vaccine Revenue in 2022
Figure 31. Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 33. Global Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 34. Global Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 35. Global Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Microneedle Flu Vaccine Revenue Share by Country (2018-2029)
Figure 41. US & Canada Microneedle Flu Vaccine Sales Share by Country (2018-2029)
Figure 42. U.S. Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 45. Europe Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 46. Europe Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 47. Europe Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 48. Europe Microneedle Flu Vaccine Revenue Share by Country (2018-2029)
Figure 49. Europe Microneedle Flu Vaccine Sales Share by Country (2018-2029)
Figure 50. Germany Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. France Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. China Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 56. China Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 57. China Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 58. China Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 59. Asia Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Asia Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Asia Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Asia Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Asia Microneedle Flu Vaccine Revenue Share by Region (2018-2029)
Figure 64. Asia Microneedle Flu Vaccine Sales Share by Region (2018-2029)
Figure 65. Japan Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. India Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales Share by Country (2018-2029)
Figure 76. Brazil Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. Microneedle Flu Vaccine Value Chain
Figure 82. Microneedle Flu Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Figure 1. Microneedle Flu Vaccine Product Picture
Figure 2. Global Microneedle Flu Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Microneedle Flu Vaccine Market Share by Type in 2022 & 2029
Figure 4. Solid Microneedle Product Picture
Figure 5. Hollow Microneedle Product Picture
Figure 6. Coated Microneedle Product Picture
Figure 7. Dissolving Microneedle Product Picture
Figure 8. Global Microneedle Flu Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Microneedle Flu Vaccine Market Share by Application in 2022 & 2029
Figure 10. Influenza A
Figure 11. Influenza B
Figure 12. Microneedle Flu Vaccine Report Years Considered
Figure 13. Global Microneedle Flu Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Microneedle Flu Vaccine Revenue 2018-2029 (US$ Million)
Figure 15. Global Microneedle Flu Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Microneedle Flu Vaccine Revenue Market Share by Region (2018-2029)
Figure 17. Global Microneedle Flu Vaccine Sales 2018-2029 ((K Dose)
Figure 18. Global Microneedle Flu Vaccine Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 20. US & Canada Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 22. Europe Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 24. China Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 26. Asia (excluding China) Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales YoY (2018-2029) & (K Dose)
Figure 28. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Microneedle Flu Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Microneedle Flu Vaccine in the World: Market Share by Microneedle Flu Vaccine Revenue in 2022
Figure 31. Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 33. Global Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 34. Global Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 35. Global Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Microneedle Flu Vaccine Revenue Share by Country (2018-2029)
Figure 41. US & Canada Microneedle Flu Vaccine Sales Share by Country (2018-2029)
Figure 42. U.S. Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 45. Europe Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 46. Europe Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 47. Europe Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 48. Europe Microneedle Flu Vaccine Revenue Share by Country (2018-2029)
Figure 49. Europe Microneedle Flu Vaccine Sales Share by Country (2018-2029)
Figure 50. Germany Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. France Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. China Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 56. China Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 57. China Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 58. China Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 59. Asia Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Asia Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Asia Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Asia Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Asia Microneedle Flu Vaccine Revenue Share by Region (2018-2029)
Figure 64. Asia Microneedle Flu Vaccine Sales Share by Region (2018-2029)
Figure 65. Japan Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. India Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Microneedle Flu Vaccine Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Microneedle Flu Vaccine Sales Share by Country (2018-2029)
Figure 76. Brazil Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Microneedle Flu Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. Microneedle Flu Vaccine Value Chain
Figure 82. Microneedle Flu Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
